France (FR)

Opinion of the Scientific Committee on Consumer safety (SCCS) - Opinion on Ethylzingerone - 'Hydroxyethoxyphenyl Butanone' (HEPB) - Cosmetics Europe No P98-CAS No 569646-79-3-Submission II (eye irritation) (2019) Bernauer U, Bodin L, Chaudhry Q, Coenraads P, Dusinska M, Ezendam J, Gaffet E, et al. Journal article, Editorial Opinion of the Scientific Committee on consumer safety (SCCS) - Final opinion on the safety of fragrance ingredient Acetylated Vetiver Oil (AVO) - (Vetiveria zizanioides root extract acetylated) - Submission III (2019) Bernauer U, Bodin L, Chaudhry Q, Coenraads P, Dusinska M, Ezendam J, Gaffet E, et al. Journal article, Editorial Early Symptom Improvement With Risankizumab Treatment in Patients With Moderately to Severely Active Crohn's Disease: Analysis From a Phase 2 Study (2019) Feagan BG, Sandborn WJ, D'Haens GR, Panes J, Kaser A, Ferrante M, Louis E, et al. Conference contribution Efficacy and Safety of Nintedanib in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease by Use of Mycophenolate at Baseline: Subgroup Analysis of the SENSCIS Trial (2019) Highland K, Distler O, Kuwana M, Allanore Y, Assassi S, Azuma A, Bourdin A, et al. Conference contribution Effect of Anti-Topoisomerase I Antibody Status on Decline in Lung Function in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease: Data from the SENSCIS Trial (2019) Mayes M, Highland K, Gahlemann M, Fischer A, Raghu G, Girard M, Alves M, et al. Conference contribution Cluster-based Spondyloarthritis Phenotypes Defined at Baseline Are Predictive of Different Severity Outcomes at 5-Year in the DESIR Cohort (2019) Costantino F, Aegerter P, Molto A, Schett G, Breban M, D'Agostino MA Conference contribution ABSORB bioresorbable scaffold versus Xience metallic stent in acute coronary syndromes with treated with percutaneous coronary intervention. A subanalysis of the COMPARE-ABSORB trial (2019) Van Geuns RJ, Smits PC, Chang CC, Wlodarczyk A, Chevalier B, West N, Gori T, et al. Conference contribution Frailty and in-hospital outcomes in percutaneous coronary interventions (2019) Kwok CS, Achenbach S, Curzen N, Fischman DL, Savage M, Bagur R, Kontopantelis E, et al. Conference contribution Antipruritic effect of bezafibrate and serum autotaxin measures in patients with primary biliary cholangitis (2019) Kremer A, Le Cleac'H A, Lemoinne S, Wolf K, De Chaisemartin L, Chollet-Martin S, Humbert L, et al. Journal article, Letter Beyond gamma-Al2O3 crystallite surfaces: The hidden features of edges revealed by solid-state H-1 NMR and DFT calculations (2019) Batista ATF, Wisser D, Pigeon T, Gajan D, Diehl F, Rivallan M, Catita L, et al. Journal article